mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0004 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0004 |
mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0008 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.0008 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0009 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
JW-480 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.002 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |